Placebo News and Research

RSS

Removing warts without scarring

If burning and freezing warts hasn't worked, ask your dermatologist about getting a shot.

19 Jul 2005

Results demonstrate the safety and tolerability of ABthrax treatment for Anthrax infection

Human Genome Sciences has announced that results published in the current issue of Clinical Infectious Diseases demonstrate that the first investigational agent against anthrax infection to be evaluated in a clinical study since the 2001 anthrax attacks in the United States, is safe, well tolerated and achieves the blood levels predicted by relevant animal models as necessary to afford significant protection from the lethal effects of the anthrax toxin

19 Jul 2005

Tamiflu may treat avian flu virus

Experiments in mice show that an antiviral drug currently used against annual influenza strains also can suppress the deadly influenza virus that has spread from birds to humans, killing dozens of people in Vietnam, Cambodia and Thailand since early 2004.

18 Jul 2005

Nebivolol may help control high blood pressure

According to research presented at ISHIB2005, nebivolol was shown to be statistically significantly better than placebo in reducing systolic and diastolic blood pressure among African-American hypertensive patients in a multicenter, randomized, double-blind, placebo-controlled study.

18 Jul 2005

New compound ruboxistaurin may decrease vision loss in diabete

A multicenter international study chaired by a Joslin Diabetes Center investigator and reported in the July issue of the American Diabetes Association's journal Diabetes brings hopeful news to the 18 million people in the United States -- and millions more worldwide -- with type 1 or type 2 diabetes.

15 Jul 2005

Current recommendations for prescribing antidepressants should be reconsidered

Most people with depression are initially treated with antidepressants, and prescribing has risen by 253% in 10 years. Yet recent studies show that SSRIs have no clinically meaningful advantage over placebo, write Joanna Moncrieff and Irving Kirsch.

14 Jul 2005

FDA panel says asthma drugs should stay on market but must carry warnings

The U.S. Food and Drug Administration (FDA) advisory panel has declared that three asthma drugs are safe enough to stay on the market, after concerns that in rare cases they raise the risk of severe asthma.

14 Jul 2005

Erlotinib increases survival in patients with advanced non-small cell lung cancer

An international clinical study led by Canadian researchers has demonstrated that a drug called erlotinib increases survival in patients with advanced non-small cell lung cancer who typically have no other treatment options.

13 Jul 2005

Australian product promotes healing in venous stasis ulcers

Novogen has announced the results of a Phase II clinical trial of its investigational wound healing compound, Glucoprime, in venous stasis ulcers.

13 Jul 2005

Menopause symptoms return with a vengence when women stop HRT

In somewhat depressing news for women battling that often miserable phase in their lives, the menopause, it appears that more than half of women who start taking hormone replacement therapy to relieve the discomfort, can expect to see a dramatic resurgence of those symptoms, when they discontinue the therapy.

12 Jul 2005

Nitric oxide good for some prem babies but not for others

According to two new studies, although nitric oxide can halve the risk of developmental problems in premature babies with undeveloped lungs, the gas could be harmful to newborns who are too small and too ill.

7 Jul 2005

Accuracy of PSA screening for detecting prostate cancer

A new study indicates there is no specific PSA value that has both high sensitivity and high specificity for monitoring healthy men for prostate cancer, but rather there is a continuum of prostate cancer risk at all values of PSA, according to a study in the July 6 issue of JAMA: The Journal of the American Medical Association.

6 Jul 2005

Novel inhibitor offsets neurotoxic effects of tPA - possible new stroke treatments

A research team lead by the Burnham Institute has synthesized and tested a new series of inhibitors that can prevent the type of nerve cell injury and death associated with many neurodegenerative diseases and stroke.

6 Jul 2005

Vitamin E fails to deliver benefits for major cardiovascular events or cancer

In an article in the July 6 JAMA, I-Min Lee, M.B.B.S., Sc.D., of Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues analyzed data from the vitamin E component of the Women's Health Study, which tested whether vitamin E supplementation decreases the risk of cardiovascular disease and cancer among healthy women.

6 Jul 2005

Aspirin can help prevent heart disease, but vitamin E no protection against cancer

It may have taken 12 years, but researchers now say that studies involving nearly 40,000 women in the U.S. has found that regular, low doses of aspirin do not prevent cancer, and vitamin E is pretty ineffective in warding off both heart disease and cancer.

6 Jul 2005

Drug therapy may be effective in treating both the manic and depressive phases of bipolar disorder

The condition (bipolar I and II) affects approximately 8 million Americans, who have relied on a combination of drugs to manage their symptoms, and who remain at high risk of committing suicide because of the difficulty in treating the disorder.

6 Jul 2005

Orthodontics takes first step toward biological control of tooth movement

In the first study of its kind, University of Florida researchers are testing the power of a natural human hormone to biochemically move teeth faster and less painfully during orthodontic treatment.

6 Jul 2005

Vitamin E supplements do not protect healthy women against heart attacks and stroke

Vitamin E supplements do not protect healthy women against heart attacks and stroke, according to new results from the Women's Health Study, a long-term clinical trial of the effect of vitamin E and aspirin on both the prevention of cardiovascular disease and of cancer.

5 Jul 2005

Bone Medical completes first trial of oral parathyroid hormone product for treatment of osteoporosis

Bone Medical Ltd announced today the completion of a Phase I trial of its oral parathyroid hormone (PTH) product Perthoxal™ under development for the treatment of osteoporosis.

3 Jul 2005

Daclizumab effective at reducing organ rejection and risk of infection in heart transplant patients

A new study shows that a drug, called daclizumab, is effective at reducing organ rejection and risk of infection in heart transplant patients. The multi-center study by cardiologists from the United States, Sweden, Germany and Canada will be published in the June 30 issue of The New England Journal of Medicine.

30 Jun 2005

Placebo News and Research

Removing warts without scarring

Results demonstrate the safety and tolerability of ABthrax treatment for Anthrax infection

Tamiflu may treat avian flu virus

Nebivolol may help control high blood pressure

New compound ruboxistaurin may decrease vision loss in diabete

Current recommendations for prescribing antidepressants should be reconsidered

FDA panel says asthma drugs should stay on market but must carry warnings

Erlotinib increases survival in patients with advanced non-small cell lung cancer

Australian product promotes healing in venous stasis ulcers

Menopause symptoms return with a vengence when women stop HRT

Nitric oxide good for some prem babies but not for others

Accuracy of PSA screening for detecting prostate cancer

Novel inhibitor offsets neurotoxic effects of tPA - possible new stroke treatments

Vitamin E fails to deliver benefits for major cardiovascular events or cancer

Aspirin can help prevent heart disease, but vitamin E no protection against cancer

Drug therapy may be effective in treating both the manic and depressive phases of bipolar disorder

Orthodontics takes first step toward biological control of tooth movement

Vitamin E supplements do not protect healthy women against heart attacks and stroke

Bone Medical completes first trial of oral parathyroid hormone product for treatment of osteoporosis

Daclizumab effective at reducing organ rejection and risk of infection in heart transplant patients

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News